MASI Add to watchlist $179.95 +0.00 (+0.00%) Last updated: Jul 15, 2026 06:00
52-Week Range
$179.95
$125.94 $179.95 $179.99

Fundamentals Overview

Masimo Corporation is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 124.1 PEG 1.07 P/B 11.91 P/S 6.05

Intrinsic value (DCF)

-82.6% downside vs price

Profitability

Net margin 4.9%

Risk (Beta)

1.18 — in line vol

Earnings & growth

EPS $1.45 Rev -2.2% Profit -16.4% vs prior qtr

BullzEye Analysis

Our composite tilts Sell on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Sell — 81% confidence Risk: Moderate Volatility — Beta 1.18. Diversify and only invest what you can afford to lose.

Pressures (Sell):

DCF 82.6% downside vs price · 3M vs S&P 500: -8.8% · 3M vs Healthcare sector: -6.1%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$9.42B
P/E (TTM)
124.05
EPS (TTM)
$1.45
Dividend Yield
N/A
52-Week Range
$125.94 - $179.99
Volume vs Avg
N/A
Beta
1.18

About

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen,...
Sector: Healthcare
Headquarters: US
Employees: 7,500
IPO Date: Aug 2007
Beta: 1.18 (More volatile than market)

Ratings & Grades at a Glance

Recent institutional grades: mixed. Current institutional positions: Buy: 7, Equal Weight: 1, Hold: 4, Market Perform: 1, Neutral: 2, Outperform: 3, Overweight: 12.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $31.23; current price is $179.95. That’s a -82.6% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 124.05
DCF value (model) $31.23 (-82.6% vs price)
PEG (TTM) 1.07
P/B (TTM) 11.91
P/S (TTM) 6.05
P/FCF (TTM) 45.13
Liquidity & enterprise
Current Ratio (TTM) 2.68
Quick Ratio (TTM) 1.45
Cash Ratio (TTM) 0.38
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 4.9%
Gross margin (TTM) 61.73%
Operating margin (TTM) 19.85%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for MASI.

Analyst Sentiment at a Glance

Sentiment Mixed
Buy 7Equal Weight 1Hold 4Market Perform 1Neutral 2Outperform 3Overweight 12
3 upgrades, 3 downgrades
Consensus Target
$180.00
High Target
$180.00
Low Target
$180.00
Median Target
$180.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Raymond James downgrade Outperform Market Perform 2026-03-27
Wells Fargo downgrade Overweight Equal Weight 2026-02-18
BTIG downgrade Buy Neutral 2026-02-18
BTIG maintain Buy Buy 2025-12-04
BTIG maintain Buy Buy 2025-11-24
Wells Fargo maintain Overweight Overweight 2025-11-05
BTIG maintain Buy Buy 2025-11-05
BTIG maintain Buy Buy 2025-09-11
Piper Sandler maintain Overweight Overweight 2025-08-06
Wells Fargo maintain Overweight Overweight 2025-05-07
Raymond James maintain Outperform Outperform 2025-05-07
Piper Sandler maintain Overweight Overweight 2025-05-07
Needham maintain Hold Hold 2025-04-10
Piper Sandler maintain Overweight Overweight 2025-02-26
Needham maintain Hold Hold 2025-02-26
Wells Fargo maintain Overweight Overweight 2025-02-26
Needham maintain Hold Hold 2025-01-22
Needham maintain Hold Hold 2025-01-16
Raymond James maintain Outperform Outperform 2024-12-27
Piper Sandler maintain Overweight Overweight 2024-12-18
Wells Fargo maintain Overweight Overweight 2024-12-11
Stifel maintain Buy Buy 2024-11-22
Wells Fargo maintain Overweight Overweight 2024-11-06
Raymond James upgrade Market Perform Outperform 2024-11-06
Piper Sandler maintain Overweight Overweight 2024-11-06
BTIG maintain Buy Buy 2024-10-14
Piper Sandler maintain Overweight Overweight 2024-08-07
Piper Sandler upgrade Neutral Overweight 2024-06-03
Piper Sandler maintain Neutral Neutral 2024-05-08
Stifel upgrade Hold Buy 2024-04-15